======= MEPCE ======= == Gene Information == * **Official Symbol**: MEPCE * **Official Name**: methylphosphate capping enzyme * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56257|56257]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7L2J0|Q7L2J0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MEPCE&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MEPCE|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611478|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: S-adenosyl-L-methionine-dependent methyltransferase that adds a methylphosphate cap at the 5'-end of 7SK snRNA, leading to stabilize it. {ECO:0000269|PubMed:17643375}. |Methyltransf 18| |Bin3| |snRNA modification| |RNA methyltransferase activity| |snRNA binding| |O-methyltransferase activity| |negative regulation of chromatin binding| |S-adenosylmethionine-dependent methyltransferase activity| |regulation of chromatin binding| |positive regulation of G1/S transition of mitotic cell cycle| |snRNA metabolic process| |positive regulation of cell cycle G1/S phase transition| |positive regulation of mitotic cell cycle phase transition| |RNA methylation| |positive regulation of cell cycle phase transition| |regulation of G1/S transition of mitotic cell cycle| |positive regulation of mitotic cell cycle| |RNA modification| |regulation of cell cycle G1/S phase transition| |negative regulation of binding| |macromolecule methylation| |positive regulation of cell cycle process| |methylation| |regulation of binding| |positive regulation of cell cycle| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |ncRNA metabolic process| |regulation of mitotic cell cycle| |regulation of cell cycle process| |negative regulation of transcription by RNA polymerase II| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |RNA metabolic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|-1.78| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|1.99| ^Gene^Correlation^ |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.453| |[[:human genes:t:tfip11|TFIP11]]|0.438| |[[:human genes:h:hexim1|HEXIM1]]|0.437| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.428| |[[:human genes:p:prpf19|PRPF19]]|0.426| |[[:human genes:p:psma6|PSMA6]]|0.425| |[[:human genes:m:madcam1|MADCAM1]]|0.423| |[[:human genes:a:arhgef15|ARHGEF15]]|0.423| |[[:human genes:c:cactin|CACTIN]]|0.411| |[[:human genes:n:nsf|NSF]]|0.411| |[[:human genes:w:wdr75|WDR75]]|0.41| |[[:human genes:m:myh7b|MYH7B]]|0.406| |[[:human genes:e:exosc9|EXOSC9]]|0.406| |[[:human genes:t:tspy8|TSPY8]]|0.403| |[[:human genes:c:cgb2|CGB2]]|0.4| Global Fraction of Cell Lines Where Essential: 142/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|6/28| |blood|4/28| |bone|9/26| |breast|8/33| |central nervous system|15/56| |cervix|0/4| |colorectal|1/17| |esophagus|2/13| |fibroblast|1/1| |gastric|2/16| |kidney|4/21| |liver|3/20| |lung|7/75| |lymphocyte|1/16| |ovary|6/26| |pancreas|0/24| |peripheral nervous system|7/16| |plasma cell|2/15| |prostate|1/1| |skin|7/24| |soft tissue|1/9| |thyroid|2/2| |upper aerodigestive|3/22| |urinary tract|2/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1317 * **Expression level (log2 read counts)**: 6.11 {{:chemogenomics:nalm6 dist.png?nolink |}}